essence study semaglutide A Placebo-Controlled Trial of Subcutaneous in Nonalcoholic Steatohepatitis ESSENCE: Semaglutide bests placebo in

Your genes determine your position on that spectrum

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Shown to improve mental performance

The cumulative incidence for NAION events was 6.7% for those prescribed semaglutide and 0.8% for those prescribed other obesity medications

Portion Tips & Texture Adjustments This White Bean & Spinach Stew makes 23 small portions, which fits well with what many call the tiny appetite phase on GLP-1 medications

Genetic insights from the optional Precision Peptide Genetic Test can identify your individual peptide-pathway predispositions, helping your provider tailor treatment intensity and timing to your biology